Ilika Plc Appoint Dr. Monika Biddulph with 20+ years of ARM IP licensing experience

Ilika plc

Ilika plc (LON: IKA), the advanced solid-state battery company, announced today the appointment of Dr. Monika Biddulph as a Non- Executive Director.

Until August 2018, Monika was a member of the Senior Leadership Team IP Product Groups at ARM Holdings plc (‘ARM’), responsible for driving the execution of the product roadmaps across all lines of business and central engineering. In over twenty years at ARM, Monika held various General Manager and licensing roles in the business. She was previously NED at Linaro Limited, an open source software organisation. Monika holds a PhD in Physics from the ETH Zurich.

Keith Jackson, Ilika plc Chairman stated:

“I am excited to have Monika joining our Board bringing over twenty years of ARM IP licensing experience and a complementary broad set of commercial and technical skills to Ilika. This is an opportune time for Monika’s appointment as the Company moves forward with its commercialisation of IP coupled with negotiating licencing terms with potential OEMs.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately ÂŁ1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Search